A study31 found that IGU downregulated INF-γ, IL-18, IL-6, and IL-17 expression in the peripheral blood of RA patients and decreased the frequency of Th17 and Th1 cells while significantly increasing the frequency of regulatory T cells (Tregs). This evidence concerns the gene IL17A and rheumatoid arthritis.